
Pacira BioSciences, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Pacira BioSciences develops and markets non-opioid pain management and regenerative health products for use in hospitals and surgical centers, including the EXPAREL liposomal bupivacaine injection used to control postsurgical pain.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| RIKER LAURENSenior Vice President, Finance | Sell | $218K | 6,000at $36.32 | Oct 8, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable PCRX activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.